| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $66.6M | +85.4% |
| SG&A Expense | $30.6M | +101.6% |
| Operating Income | -$97.2M | -90.2% |
| Income Tax | $0 | — |
| Net Income | -$94.6M | -84.9% |
| EPS (Basic) | -$3.02 | +63.0% |
| EPS (Diluted) | -$3.02 | +63.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $45.2M | -84.5% |
| Current Assets | $209.9M | -29.7% |
| Total Assets | $252.1M | -17.6% |
| Current Liabilities | $22.0M | +227.0% |
| Total Liabilities | $39.5M | +455.2% |
| Stockholders' Equity | $212.6M | -28.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$93.8M | -84.4% |
| Capital Expenditures | $2.9M | -37.0% |
| Investing Cash Flow | -$148.7M | -3145.6% |
| Financing Cash Flow | $479K | -99.8% |
| Free Cash Flow | -$96.7M | -74.4% |